Suppr超能文献

中欧地区根治性膀胱切除术的时机——关于影响膀胱癌患者从诊断到根治性治疗时间的因素的多中心研究

Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients.

作者信息

Poletajew Sławomir, Braticevici Bogdan, Brisuda Antonín, Cauni Victor, Grygorenko Viacheslav, Lesnyak Martyn-Zenovii, Lisiński Janusz, Persu Cristian, Renk Kacper, Radziszewski Piotr

机构信息

Medical University of Warsaw, Department of Urology, Warsaw, Poland.

Burghele Clinical Hospital, Department of Urology, Bucharest, Romania.

出版信息

Cent European J Urol. 2015;68(1):9-14. doi: 10.5173/ceju.2015.01.444. Epub 2014 Dec 17.

Abstract

INTRODUCTION

Time that passes between an unfavourable diagnosis to a radical cystectomy (RC) affects oncological outcomes in patients with bladder cancer. Unsatisfactory survival of patients after RC in Central Europe can potentially result from this factor.

MATERIAL AND METHODS

The aim of this study was to assess the time interval between transurethral resection of the bladder tumor (TURBT) and RC in Central Europe and to identify clinical factors of possible delays. 941 consecutive patients who underwent RC in nine Central European urological centers were enrolled into the study. After the TURBT-RC time was calculated, selected clinical and pathological parameters were tested as potential factors influencing the timing of RC.

RESULTS

On average, RCs were performed 73.8 days after TURBTs (median - 53, range 0-1587). In 238 patients (25.3%) the time exceeded 12 weeks. Patients with muscle-invasive cancer were operated earlier on than patients with nonmuscle-invasive cancer (67.6 vs.105.2 days, RR = 1.41, p = 0.00). In high volume centers (>30 RC per year) longer TURBT-RC intervals were observed (97.6 vs. 66.3 days, RR = 2.49, p = 0.00). Simultaneously, factors such as female sex (RR = 1.21), more advanced age of patient (>65 years, RR = 1.23), presence of concomitant CIS (RR = 2.43), grade of cancer cells (RR = 1.67) and final post-RC stage (RR = 1.51) had no statistically significant effect on the results (p >0.05).

CONCLUSIONS

The mean time interval between the diagnosis and radical treatment of patients with bladder cancer in Central Europe is adequate. However, there are still a relatively high number of patients waiting for radical cystectomy longer than 8 weeks. A lower stage of disease as well as a higher case load within of a hospital may delay the surgery.

摘要

引言

从不良诊断到根治性膀胱切除术(RC)之间所经历的时间会影响膀胱癌患者的肿瘤学结局。中欧地区患者根治性膀胱切除术后生存率不尽人意可能源于这一因素。

材料与方法

本研究旨在评估中欧地区经尿道膀胱肿瘤切除术(TURBT)与根治性膀胱切除术之间的时间间隔,并确定可能导致延迟的临床因素。连续纳入了在九个中欧泌尿外科中心接受根治性膀胱切除术的941例患者。计算出TURBT-RC时间后,对选定的临床和病理参数进行检测,以确定其是否为影响根治性膀胱切除术时机的潜在因素。

结果

平均而言,根治性膀胱切除术在经尿道膀胱肿瘤切除术后73.8天进行(中位数为53天,范围为0-1587天)。238例患者(25.3%)的时间超过了12周。肌层浸润性癌患者比非肌层浸润性癌患者更早接受手术(67.6天对105.2天,RR = 1.41,p = 0.00)。在高手术量中心(每年>30例根治性膀胱切除术),观察到更长的TURBT-RC间隔时间(97.6天对66.3天,RR = 2.49,p = 0.00)。同时,女性性别(RR = 1.21)、患者年龄较大(>65岁,RR = 1.23)、合并原位癌(RR = 2.43)、癌细胞分级(RR = 1.67)和根治性膀胱切除术后最终分期(RR = 1.51)等因素对结果无统计学显著影响(p>0.05)。

结论

中欧地区膀胱癌患者从诊断到根治性治疗的平均时间间隔是合适的。然而,仍有相当数量的患者等待根治性膀胱切除术的时间超过8周。疾病分期较低以及医院内病例数量较多可能会延迟手术。

相似文献

8
High-Grade Non-Muscle Invasive Bladder Cancer: When to Move to Early Radical Cystectomy?
Cureus. 2021 Nov 9;13(11):e19399. doi: 10.7759/cureus.19399. eCollection 2021 Nov.
10
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.
World J Urol. 2019 Dec;37(12):2707-2714. doi: 10.1007/s00345-019-02734-6. Epub 2019 Mar 25.

引用本文的文献

4
Years of life lost due to bladder cancer among the inhabitants of Poland in the years 2000 to 2014.
Cent European J Urol. 2017;70(4):338-343. doi: 10.5173/ceju.2017.1521. Epub 2017 Sep 22.
5
Endoscopic appearance of a tumor can predict the stage of bladder cancer.
Cent European J Urol. 2017;70(1):27-28. doi: 10.5173/ceju.2017.1242. Epub 2017 Mar 14.
6
Histopathological evaluation is still useful after bladder neck resection.
Cent European J Urol. 2016;69(4):358-359. doi: 10.5173/ceju.2016.942. Epub 2016 Nov 30.
7
Author'S reply.
Cent European J Urol. 2015;68(1):17. doi: 10.5173/ceju.2015.01.r95.
8
Optimized management in patients with bladder cancer.
Cent European J Urol. 2015;68(1):15-6. doi: 10.5173/ceju.2015.01.e93.

本文引用的文献

1
The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres - results of CysTiming Poland study.
Cent European J Urol. 2014;67(4):329-32. doi: 10.5173/ceju.2014.04.art2. Epub 2014 Dec 5.
2
Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study.
Cancer. 2014 Jun 1;120(11):1630-8. doi: 10.1002/cncr.28510. Epub 2014 Apr 14.
3
Tissue engineering of urinary bladder - current state of art and future perspectives.
Cent European J Urol. 2013;66(2):202-6. doi: 10.5173/ceju.2013.02.art23. Epub 2013 Aug 13.
4
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.
Eur Urol. 2014 Apr;65(4):778-92. doi: 10.1016/j.eururo.2013.11.046. Epub 2013 Dec 12.
5
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12.
6
The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Eur Urol. 2013 May;63(5):839-45. doi: 10.1016/j.eururo.2013.01.004. Epub 2013 Jan 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验